[ad_1]
- Beyrer C
- Das P
- Horton R
- Ryan O
- Bekker LG
,
- Bekker LG
- Alleyne G
- Baral S
- et al.
Our vision was challenging for many in these vital domains. Concerns about global public health governance, the need to address weak and fragile health systems, and the financing of these ambitious goals were raised and debated.
- Bekker LG
- Ratevosian J
- Spencer J
- Piot P
- Beyrer C
Now, 2 years later, humanity is facing another viral pandemic, coronavirus disease 2019 (COVID-19), with coronavirus 2 of severe acute respiratory syndrome as the causative agent. The COVID-19 pandemic is profoundly challenging health systems, national economies, global health governance structures, and the many advances we have made in human health and global solidarity.
Coronavirus Disease Situation Report 2019 (COVID-19): 99.
And it’s already the deadliest new pandemic since the onset of AIDS nearly 40 years ago. To address the many interactions of this pandemic with HIV and populations affected by HIV disproportionately, the IAS announced on April 16, 2020, an expanded conference program to include COVID-19 and HIV interactions in its call for last minute summaries. The IAS is well aware of how many of our members worldwide participate in the COVID-19 response across the spectrum of science, clinical care, prevention and policy. In fact, in many countries, some of the leaders in responses to COVID-19 have a history of HIV. In the USA For example, the three COVID-19 public health leaders, Anthony Fauci of the US National Institutes of Health. USA, Deborah Birx, of the Emergency Plan of the President of EE. USA For AIDS Relief, and Robert Redfield of the US Centers for Disease and Control. USA Prevention, they are all distinguished HIV researchers and leaders.
The IAS COVID-19 virtual conference in AIDS 2020: virtual It will be the first international meeting on COVID-19 for all stakeholders, including affected communities, in the emerging response. There will be special invited sessions of COVID-19 and IAS announced today, on April 30, 2020, a call for submission of specific abstracts of COVID-19, including exploratory studies, from researchers, physicians and policy makers from around the world; The deadline for submission of specific COVID-19 abstracts is May 25, 2020, and more information can be found on the IAS COVID-19 Virtual Conference website. Selected summaries will guide sessions on the full range of COVID-19 topics, from pathogenesis to clinical care and treatment, vaccines, public health strategies, global preparedness, and human rights. Finally, to ensure full access to specific COVID-19 programming for global communities, those sessions will be made public and free.
Three lessons for the COVID-19 response to the HIV pandemic.
The IAS COVID-19 virtual conference in AIDS 2020: virtual It will bring together the human family to face this pandemic. Together we can build resilience against COVID-19.
AP reports research grants and personal fees from Gilead, Merck, Janssen, and ViiV and is president of the International AIDS Society. MG and CB report grants from the US National Institutes of Health. USA We do not declare other competing interests.
References
- one)
The International AIDS SocietyLancet Commission on the future of the HIV response and global health.
Lancet. 2017; 390: 344-345
- 2)
Advancing global health and strengthening the response to HIV in the era of the Sustainable Development Goals: the International AIDS Society –Lancet Commission.
Lancet. 2018; 392: 312-358
- 3)
Governance for health: the response to HIV and global health in general.
Bull World Health Organ. 2019; 97 (): 170
- 4)
Coronavirus Disease Situation Report 2019 (COVID-19): 99.
- 5)
Three lessons for the COVID-19 response to the HIV pandemic.
Lancet HIV. 2020; ()
Item information
History of publications
Posted: April 30, 2020
ID
DOI: https://doi.org/10.1016/S0140-6736(20)31026-6
Copyright
© 2020 Elsevier Ltd. All rights reserved.
ScienceDirect
Access this article on ScienceDirect
